OncoSec Medical Inc. | Income Statement
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
736.90
780.10
664.60
355.60
380.00
334.50
Gross Income
736.90
780.10
664.60
355.60
380.00
334.50
SG&A Expense
6,328.10
11,169.60
20,576.50
26,530.50
21,068.40
35,770.90
EBIT
7,065.00
11,949.70
21,241.10
26,886.10
21,448.40
36,105.40
Interest Expense
83.20
20.70
-
-
-
-
Pretax Income
7,148.20
11,970.30
21,241.10
26,886.10
21,448.40
39,135.70
Income Tax
2.00
41.80
2.00
2.50
1.40
0.70
Consolidated Net Income
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
Net Income
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
Net Income After Extraordinaries
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
Net Income Available to Common
7,150.20
12,012.10
21,243.10
26,888.50
21,449.80
39,136.40
EPS (Basic)
1.40
1.20
1.67
1.63
1.06
9.80
Basic Shares Outstanding
5,327.90
9,527.20
12,709.00
16,514.70
20,189.70
4,012.30
EPS (Diluted)
1.34
1.26
1.67
1.63
1.06
9.75
Diluted Shares Outstanding
5,327.90
9,527.20
12,709.00
16,514.70
20,189.70
4,012.30
EBITDA
6,328.10
11,169.60
20,576.50
26,530.50
21,068.40
35,770.90
About OncoSec Medical
View Profile
